MsRI-EW: Planning the Infrastructural Needs to Meet National Research Demand and Support the United States' Leadership in Biomanufacturing
- Funded by National Science Foundation (NSF)
- Total publications:0 publications
Grant number: 2035203
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$49,989Funder
National Science Foundation (NSF)Principal Investigator
Carolyn YeagoResearch Location
United States of AmericaLead Research Institution
Georgia Tech Research CorporationResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Therapeutics logistics and supply chains and distribution strategies
Special Interest Tags
Data Management and Data SharingInnovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The recent global pandemic has highlighted some critical areas for improvement in delivering safe and effective therapeutics. An infrastructure that enables rapid, on-demand manufacturing of emerging therapies is critical to maintaining the health of the American people. This conference will bring together representatives from the public and private sectors. The conference will investigate all major aspects of vaccine and therapeutic development and production. The objective is to develop a roadmap to drive innovative biomanufacturing research and development.
Issues to be addressed include infrastructure to characterize products for clinical trials and regulatory approval; cyberinfrastructure to provide secure communication and storage of research data; artificial intelligence and machine learning tools to accelerate research progress; and automation technologies to enable new, disruptive manufacturing technologies for vaccines and therapeutics. The conference will have virtual sessions covering (1) cell/gene manufacturing, (2) emerging vaccine manufacturing, and (3) data integration, analytics, security, and management. Experts within each session will represent clinical research and application, academia, governmental agencies, and the industrial value chain. Cross-cutting topics will be discussed in terms of needed infrastructure to support accelerated and expanded research efforts. These cross-cutting topics include Scale-up, Automation, Supply Chain, and Education and Workforce.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Issues to be addressed include infrastructure to characterize products for clinical trials and regulatory approval; cyberinfrastructure to provide secure communication and storage of research data; artificial intelligence and machine learning tools to accelerate research progress; and automation technologies to enable new, disruptive manufacturing technologies for vaccines and therapeutics. The conference will have virtual sessions covering (1) cell/gene manufacturing, (2) emerging vaccine manufacturing, and (3) data integration, analytics, security, and management. Experts within each session will represent clinical research and application, academia, governmental agencies, and the industrial value chain. Cross-cutting topics will be discussed in terms of needed infrastructure to support accelerated and expanded research efforts. These cross-cutting topics include Scale-up, Automation, Supply Chain, and Education and Workforce.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.